Journal Club: Myeloid sarcoma- The clinical, morphological, and immunohistochemical features Dr. Nandita Mohan26 April 2025 10:00 AM ISTThis is an original article published in the Asian Journal of Oncology published by Scientific Scholar.To give a brief about Myeloid sarcoma (MS), it...
Wockhardt Zaynich successfully treats paediatric cancer patient with recalcitrant blood, liver infection Ruchika Sharma1 April 2025 12:15 PM ISTThe patient was treated with Zaynich for 41 days, resulting in the successful resolution of the infection.
Common BP drug may make leukemia more responsive to chemotherapy while protecting heart: Study Dr. Kamal Kant Kohli30 Jun 2024 8:30 PM ISTResearchers from the University of Missouri School of Medicine found that a targeted gene therapy may make acute myeloid leukemia (AML) more sensitive...
Breastfeeding may reduce risk of leukemia in children Aditi16 Sept 2023 9:45 AM ISTAcute leukemia (AL) is the most common type of cancer in children under 15 years old in most populations. The reported world age-standardized...
Daiichi Sankyo Vanflyta gets US FDA nod for patients with newly diagnosed FLT3-ITD positive AML Ruchika Sharma23 July 2023 12:00 PM ISTTokyo: Daiichi Sankyo has announced that VANFLYTA (quizartinib) has been approved by the U.S. Food and Drug Administration (FDA) in combination with...
USFDA extends review period for Daiichi Sankyo acute myeloid leukemia drug Quizartinib Ruchika Sharma23 April 2023 4:00 PM ISTQuizartinib is an oral, highly potent type II FLT3 inhibitor that selectively targets FLT3-ITD mutations and has been specifically developed for...
Maternal urinary and genital tract infections during pregnancy tied to childhood leukaemia in offspring: JAMA Aditi7 April 2023 9:45 AM ISTChina: An Original Investigation of Pediatrics published in JAMA Network Open has concluded that maternal urinary and genital tract infections during...
Blood test may predict risk of relapse after bone marrow transplant in acute myeloid leukemia patients Dr. Kamal Kant Kohli14 March 2023 8:00 PM ISTResearchers at the National Institutes of Health have devised strategy to predict risk of relapse after bone marrow transplant in acute myeloid...
Investigational drug Shows Survival Benefit For Some Leukemia Patients in Phase 3 study Dr. Kamal Kant Kohli14 Jun 2022 7:00 AM ISTAn investigational drug taken while undergoing chemotherapy demonstrated superior overall survival compared to chemotherapy alone in adult patients...
USFDA lifts partial clinical hold on studies evaluating magrolimab in combination with azacitidine: Gilead Sciences Ruchika Sharma12 April 2022 4:49 PM ISTFoster City: Gilead Sciences, Inc. has recently announced that the U.S. Food and Drug Administration (USFDA) has lifted the partial clinical hold...
Prophylactic antibiotics lower infection risk in children with acute myeloid leukemia: Study Medical Dialogues Editorial Team30 Jan 2022 12:15 PM ISTTaiwan: According to a new study, prophylactic antimicrobial administration in children with acute myeloid leukemia (AML) who are undergoing...
Venetoclax combination therapies found effective against challenging subtypes of acute myeloid leukemia Hina Zahid21 Dec 2021 9:00 AM ISTATLANTA - Combination therapies including venetoclax and another therapy have displayed promising results against subtypes of acute myeloid leukemia...
